Boulla LLC recalls PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.Peak
Recalled December 11, 2024 · FDA recall D-0084-2025 · Boulla
Hazard
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac. · FDA Class I
Units
Unknown
Sold at
Nationwide within the United States
Description
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
Product
PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com
Manufacturer(s)
Boulla LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →